|
|
| (11) | Number of the document | |
| (68) | Number of the document | 3115 |
| (21) | Application number for Supplementary Protection Certificate | PA 2004 016 |
| (22) | Date of filing the application | 2004-10-29 |
| (41) | Date of publication of the application | 2004-12-27 |
| Date of publication of SPC | ||
| (24) | Date of coming into effect of SPC |
| (71) |
F. Hoffmann-La Roche AG,
124 Grenzacherstrasse, CH-4002 Basle,
CH
|
| (73) |
F. Hoffmann-La Roche AG,
124 Grenzacherstrasse, CH-4002 Basle,
CH
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (93) | EU/1/00/163/001, EU/1/00/163/002, 2004-02-02 |
| (95) | Capecitabinum ([1-(5-deoksi-beta-D-ribofuranozil)-5-fluor-1,2-dihidro-2-okso-4-pirimidinil]-karbamo rūgšties pentilo esteris) |
| SPC application rejected |